Article
Gene Signature in Melanoma Associated With Clinical Activity
1 Jul 2010
Abstract excerpt
Immunotherapeutic approaches for melanoma and other cancers can impart profound clinical benefit but only for a subset of patients. Interpatient heterogeneity could, in principle, be due to somatic differences in the tumor between individuals or alternatively be accounted for distinct germline polymorphisms in immunoregulatory genes of the host. Analysis of these possibilities has been initiated by investigating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
